Rising prevalence of different urological disorders is resulting into revenue-generation opportunities for manufacturers of surgical microscopes
Wilmington, Delaware, United States, June 13, 2022 (GLOBE NEWSWIRE) -- A study by Transparency Market Research (TMR) states that the global surgical microscopes market is estimated to register growth at a CAGR of 8.3% during the forecast period, 2022-2031. The assessment focuses on providing crucial insights including key market segments in surgical microscopes.
Surgical microscopes manufacturers are focusing on the introduction innovative features and next-gen imaging modalities in their products. Hence, they are seen investing heavily in R&Ds. This factor is projected to play vital role in the global surgical microscopes market expansion during the forecast period.
Over the period of past few years, there has been a surge in the cases of urological disorders such as chronic kidney disease (CKD), end-stage renal disease (ESRD), bladder and prostate cancer, kidney and ureteral stones, and urinary incontinence. According to a study by Global Forum on Incontinence (GFI), approximately 400 million people (which is around 4-8% of the global population) were dealing with urinary incontinence in 2018. Moreover, the prevalence of urinary incontinence is expected to rise in the forthcoming years due to increase in the number of obese populace, which is at higher risk factor for urinary incontinence. This factor, in turn, is prognosticated to drive the sales growth in the surgical microscopes market, notes a study by TMR.
Request Brochure of Surgical Microscopes Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23702
Surgical Microscopes Market: Key Findings
Surgical interventions for safety as well as precise patient outcomes include advancements in the 3D modelling, computer-assisted simulation and procedures planning, and imaging. These advancements are gaining traction across the healthcare sector as they help physicians in timely decision on disease diagnosis and treatment plan for the same. Moreover, surgical interventions also help healthcare providers to decide if a surgery went as per the plan.
The incorporation of different technological advancements including image injection, 4K video, robotics, and advanced fluorescence-based digital processing has resulted into transformation of conventional surgical microscope into a highly sophisticated tool that offers advanced images and additional data that can assist surgeons in making informed decisions. Owing to this factor, the revenue of the surgical microscopes market is estimated to be reach at a value of over US$ 1.7 Bn by 2031.
Request for Analysis of COVID-19 Impact on Surgical Microscopes Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=23702
Surgical Microscopes Market: Growth Boosters
Surge in the number of the older population and surgical procedures across the globe is creating largest opportunity for the surgical microscopes market
Technological innovations in the healthcare infrastructure of several developed and developing nations and a surge in the need for high-speed diagnostics are driving the market growth
Surgical Microscopes Market: Regional Analysis
The surgical microscopes market in North America is projected to maintain its prominent position during the forecast period owing to many factors including the presence of leading market players and increasing investment by these players in R&Ds. Moreover, surge in cases of oncology and cardiovascular disorders, specifically in Canada and the U.S., is likely to help in the regional market growth during the forecast period.
The surgical microscope market in Europe is estimated to show profitable prospects in the forthcoming years owing to factors such as the existence of many key players and easy accessibility to skilled workforce in the region
Get Exclusive PDF Sample Copy of Surgical Microscopes Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23702
Surgical Microscopes Market: Key Players
Some of the key players profiled in the report are:
Leica Microsystems (Subsidiary of Danaher)
HAAG-STREIT GROUP (Metall Zug Group)
Takagi Ophthalmic Instruments Europe Ltd.
ATMOS MedizinTechnik GmbH & Co. KG
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=23702
Hospitals & Ambulatory Surgical Centers
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Healthcare Research Reports by Transparency Market Research:
ACL Reconstruction Procedures Market: Increase in incidence of sports injuries, rise in prevalence of orthopedic diseases, surge in patient burden suffering from anterior crucial ligament tear, and increase in demand for ACL reconstruction procedures are the major factors anticipated to drive the global ACL reconstruction procedures market during forecast period.
Dental Equipment Market: Rise in incidences of tooth decay and gum disorders, along with rise in dental procedures such as teeth whitening, cavity treatment, dental bonding, cosmetic dental implants, and cosmetic crown implants is fueling the demand of the dental equipment across the globe.
Neuroscience Market: Dementia, Alzheimer's disease, and Parkinson's disease, advancements in the field of neuro-technology and neuroscience, and surge in government funding and initiatives in neuroscience are the key factors projected to fuel the growth of the global neuroscience market during the forecast period.
Breast Reconstruction Market: Rise in prevalence of breast cancer, increase in number of breast reconstruction procedures, and surge in demand for acellular dermal matrix are projected to drive the global breast reconstruction market.
Digital Dentistry Materials & Systems Market: Technological advancements, rise in prevalence of dental diseases, and increase in geriatric population in need of dental surgeries are projected to propel the global market during the forecast period.
Endosurgery Devices Market: Technological advancements and increase in the number of surgeries are projected to be major drivers of the global endosurgery devices market during the forecast period. Technological advancements in endosurgery devices provide enhanced surgical options for bariatric and gynecology surgery applications
Surgery Tables Market: The global surgical tables market has benefited significantly from a rise in investments in the health care sector. Moreover, an emerging trend that has had a direct impact on the surgery tables market is the use of sophisticated surgical tables to support hybrid operating rooms.
Monopolar Electrosurgery Market: Rise in demand for cost-effective monopolar electrosurgery devices, especially in emerging countries such as China, India, and Brazil, owing to surge in number of laparoscopic surgeries being performed across the world is projected to drive the global monopolar electrosurgery market during the forecast period.
Transparency Market Research (TMR) is a global market intelligence company providing market research reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: http://www.transparencymarketresearch.com Blog: https://tmrblog.com Email: sales@transparencymarketresearch.com
When GSK spins off its consumer health division in July, it will become one of the last drug conglomerates to shed its sideline businesses to focus on biotech-style medicines. The shift has big implications for investors—and overall public health.
One beloved aardvark may have left us earlier this year when “Arthur” ended its 25-year run on PBS, but the San Diego Zoo has us covered with the arrival of a new aardvark cub, the first one born to the zoo in almost 40 years. Today in health care, the wait is (almost) finally over…
New cases of skin cancer in 2022 number in the millions. Skin cancer is the number 1 type of cancer in the US. There are many different types of skin cancer. The most common are basal cell and squamous cell carcinomas, then melanoma. In 2022 it is expected that about 7,650 people are expected to die of melanoma. About 2,000 people in the US die each year from basal and squamous cell skin cancers.These types of skin cancer are usually curable if caught early. However, they can be deadly if left u
The Food and Drug Administration took the advice of a panel of advisers and authorized the COVID-19 vaccines developed by BioNTech and Pfizer and Moderna for children as young as six months old on Friday, adding the final group to the nation's vaccine program.
The Massachusetts life sciences industry is rife with companies developing drugs and devices to tackle serious diseases, inking new partnership deals, raising money, expanding facilities and more. Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of health care happenings. Canada approves Amylyx drug Amylyx Pharmaceuticals Inc. (Nasdaq: AMLX) scored its first-ever approval from Health Canada for its amyotrophic lateral sclerosis (ALS) drug Albrioza.
Prostate cancer patients can be saved from undergoing chemotherapy after new research found a way to “treat smarter, not harder”.
The two engaged in their usual heated debate at a Senate HELP Committee hearing on Thursday.
Yahoo Finance Live’s Brian Sozzi reports that the FDA has authorized Moderna and Pfizer COVID vaccines for children under the age of 5.
Is Pfizer stock a buy after the FDA signed off on its Covid vaccine for babies and toddlers? Is PFE stock a buy right now?
"I didn't know I was in labor until I was crowning, and I've had a baby before."View Entire Post ›
Florida doctors will be able to order COVID-19 vaccines for children under 5 from the federal government, the White House said Friday, after Republican Gov. Ron DeSantis said the state would not order and distribute the shots in the state. The state was the only jurisdiction in the nation to decline to place advance orders for the pediatric shots, which received authorization from the Food and Drug Administration on Friday. Final authorization from the Centers for Disease Control and Prevention is expected in the coming days, clearing the way for the last remaining unvaccinated age group to obtain shots. The White House has been sharply critical of DeSantis’ position but in a statement Friday it welcomed the news that he was permitting individual doctors to order vaccines for their patients.
Acadia Pharmaceuticals Inc. said Friday its stock will be halted from trading Friday as a U.S. Food and Drug Administration panel meets virtually to discuss a new drug application for a treatment for hallucinations and delusions associated with Alzheimer's disease psychosis. The FDA's Psychopharmacologic Drugs Advisory Committee will review Acadia's Nuplazid at a meeting scheduled for 8:45 a.m. Eastern. About six million people living in the U.S. have Alzheimer's disease, according to the Alzhei
Syndax Pharmaceuticals has toiled for years toward finding cancer therapies that can improve the lives of patients.
The U.S. Senate has passed a bill to improve health care benefits for veterans exposed to toxic burn pits.
After more than two years of pandemic life, many people are familiar with the worry and fear that can be triggered by a sore throat, sniffle or fatigue: Do I have covid-19? That thought often prompts a rush to grab the nearest home coronavirus test kit or find a testing site. But sometimes when the test comes back negative, the result can have a seemingly miraculous effect. "This morning I felt tired, maybe a sore throat, was that a hint of a headache??" tweeted Vice senior staff writer Shayla L
Can your blood type predict your risk of disease and illness? "While your blood type may put you at a higher risk for certain conditions, nothing is definitive. Being aware of how your blood type may impact your health is a good start, but it's also just as important to see your physician for regular check-ups and maintain a healthy lifestyle," says Douglas Guggenheim, MD. Here are the blood types most commonly associated with disease. Read on—and to ensure your health and the health of others,
It follows experts’ warnings this week that a new wave of COVID is 'kicking off' in England.
Tiny morsels of coconut shrimp lodged in my throat and wouldn’t budge. My eyes grew wide. I drank water fast, desperate to get the food down — the liquid shot up my nose. My heart beat faster. Should I rush to an emergency room in a foreign country? I was away in Turks and Caicos in late April. Since losing my Cuban immigrant parents and ending a seven-year relationship, traveling has become even more cathartic, and visiting beach countries is especially peaceful. But until this spring, I’d neve
A Kaiser Health News poll finds one-quarter of American adults with health care debt owe more than $5,000 and one in five of those who have any debt say they don't expect to ever pay it off. CBS News consumer investigative correspondent Anna Werner spoke with a family whose medical debt continues to follow them.
Today (June 15), a US Food and Drug Administration (FDA) panel for the first time endorsed a covid-19 vaccine for children under five years old; emergency use authorization (EUA), which would make the vaccines available, is expected to follow as early as Friday (we will update this article if/when that happens). The endorsement comes after the FDA panel reviewed the clinical trial data for vaccines made by Moderna and Pfizer-BioNTech.